Compound 27 manufacturers
- BTK inhibitor 1
-
- $97.00 / 1mg
-
2025-11-09
- CAS:2230724-66-8
- Min. Order:
- Purity: 99.79%
- Supply Ability: 10g
|
| | Compound 27 Basic information |
| Product Name: | Compound 27 | | Synonyms: | Compound 27;BTKinhibitor1(Compound27);BTK inhibitor 27;1,2,4-Oxadiazole-3-carboxamide, 5-(1,1-dimethylethyl)-N-[[2-fluoro-4-[6-(1-methyl-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]phenyl]methyl]-;5-(tert-Butyl)-N-(2-fluoro-4-(6-(1-methyl-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)benzyl)-1,2,4-oxadiazole-3-carboxamide;BTK inhibitor 1, 10 mM in DMSO | | CAS: | 2230724-66-8 | | MF: | C24H23FN8O2 | | MW: | 474.49 | | EINECS: | | | Product Categories: | | | Mol File: | 2230724-66-8.mol |  |
| | Compound 27 Chemical Properties |
| density | 1.44±0.1 g/cm3(Predicted) | | pka | 11.00±0.50(Predicted) |
| | Compound 27 Usage And Synthesis |
| Uses | BTK inhibitor 8 (Compound 27) is a Btk inhibitor with an IC50 of 0.11 nM. BTK inhibitor 8 inhibits B cell activation in hWB with an IC50 of 2 nM[1]. | | References | [1] Musumeci F, et al. Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors. Expert Opin Ther Pat. 2017 Dec;27(12):1305-1318. DOI:10.1080/13543776.2017.1355908 |
| | Compound 27 Preparation Products And Raw materials |
|